Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1023 studies found for:    Open Studies | "Arthritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting CPMC Early Undifferentiated Arthritis Registry
Condition: Arthritis
Intervention:
2 Recruiting Discovering the Antecedents of Rheumatoid Arthritis Flare
Condition: Rheumatoid Arthritis
Intervention:
3 Recruiting Pro-calcitonin for Early Detection of Septic Arthritis
Condition: Arthritis, Infectious
Intervention:
4 Recruiting NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint
Condition: Knee Arthritis
Interventions: Drug: Morphine Sulfate;   Drug: Triamcinolone;   Drug: placebo
5 Recruiting The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Dietary Supplement: Protein;   Dietary Supplement: Carbohydrate (Placebo);   Other: Resistance Exercise Program
6 Recruiting Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Procedure: Laser Based Photoacoustic Tomography, MRI, Ultrasound;   Procedure: laser based photoacoustic tomography, MRI, ultrasound
7 Not yet recruiting REMission INDuction in Very Early Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Other: Taper
8 Recruiting Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Iguratimod
9 Recruiting A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation
Condition: Psoriatic Arthritis
Interventions: Biological: adalimumab;   Drug: methotrexate (MTX)
10 Recruiting Rheumatoid Arthritis Patients and Porphyromonas Gingivalis
Condition: Rheumatoid Arthritis
Interventions: Procedure: blood sample;   Procedure: synovial tissue
11 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
12 Recruiting Reduced Ultrasound Counts in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
13 Recruiting Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment
Condition: Rheumatoid Arthritis
Interventions: Device: Xrays;   Device: Ultrasound (B mode );   Device: Ultrasound (D mode)
14 Recruiting ACTH Gel Therapy in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: ACTHAR gel
15 Recruiting Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naïve Psoriatic Arthritis Patients
Condition: Psoriatic Arthritis
Interventions: Drug: Golimumab;   Drug: Methotrexate;   Drug: Placebo
16 Recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: CFZ533;   Drug: Placebo
17 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
18 Recruiting Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Other: PRO data utilized;   Other: PRO data not utilized
19 Recruiting Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: Secukinumab
20 Recruiting A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
Condition: Rheumatoid Arthritis
Interventions: Drug: E6011;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.